Nimotuzumab Plus Paclitaxel and Cisplatin as a 1st-Line Treatment for Esophageal Cancer: Long Term Follow-up of a Phase II Study.
Zhang X, Jia J, Lu M, Wang X, Gong J, Li J, Li J, Li Y, Zhang X, Lu Z, Zhou J, Yu J, Sun Z, Yang Y, Liu C, Xiao Y, Shen L.
Zhang X, et al.
J Cancer. 2019 Feb 23;10(6):1409-1416. doi: 10.7150/jca.28659. eCollection 2019.
J Cancer. 2019.
PMID: 31031851
Free PMC article.